JP2015501782A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501782A5
JP2015501782A5 JP2014539984A JP2014539984A JP2015501782A5 JP 2015501782 A5 JP2015501782 A5 JP 2015501782A5 JP 2014539984 A JP2014539984 A JP 2014539984A JP 2014539984 A JP2014539984 A JP 2014539984A JP 2015501782 A5 JP2015501782 A5 JP 2015501782A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
heteroaryl
group
perfluoroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015501782A (ja
JP6215832B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/061597 external-priority patent/WO2013066684A1/en
Publication of JP2015501782A publication Critical patent/JP2015501782A/ja
Publication of JP2015501782A5 publication Critical patent/JP2015501782A5/ja
Application granted granted Critical
Publication of JP6215832B2 publication Critical patent/JP6215832B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539984A 2011-11-04 2012-10-24 アミノピリミジンキナーゼ阻害剤 Expired - Fee Related JP6215832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161555617P 2011-11-04 2011-11-04
US61/555,617 2011-11-04
PCT/US2012/061597 WO2013066684A1 (en) 2011-11-04 2012-10-24 Aminopyrimidine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2015501782A JP2015501782A (ja) 2015-01-19
JP2015501782A5 true JP2015501782A5 (enExample) 2015-12-17
JP6215832B2 JP6215832B2 (ja) 2017-10-18

Family

ID=47116510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539984A Expired - Fee Related JP6215832B2 (ja) 2011-11-04 2012-10-24 アミノピリミジンキナーゼ阻害剤

Country Status (14)

Country Link
US (3) US8927525B2 (enExample)
EP (1) EP2776432B1 (enExample)
JP (1) JP6215832B2 (enExample)
KR (1) KR101990605B1 (enExample)
CN (1) CN104011046B (enExample)
AU (1) AU2012332931B2 (enExample)
BR (1) BR112014010563B1 (enExample)
CA (1) CA2853454C (enExample)
ES (1) ES2629690T3 (enExample)
IL (1) IL232234A0 (enExample)
MX (1) MX347191B (enExample)
PL (1) PL2776432T3 (enExample)
RU (1) RU2674017C2 (enExample)
WO (1) WO2013066684A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102884062B (zh) * 2009-12-23 2016-08-03 嘉世高制药公司 氨基嘧啶激酶抑制剂
AU2012245344B2 (en) * 2011-04-22 2017-11-09 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
CN104011046B (zh) 2011-11-04 2017-05-03 嘉世高制药公司 氨基嘧啶激酶抑制剂
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
LT2945939T (lt) 2013-01-15 2020-07-27 Incyte Holdings Corporation Triazolkarboksamidai ir piridinkarboksamido junginiai, naudotini kaip pim kinazės inhibitoriai
EP3036238A1 (en) 2013-08-23 2016-06-29 Incyte Corporation Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
US9540347B2 (en) 2015-05-29 2017-01-10 Incyte Corporation Pyridineamine compounds useful as Pim kinase inhibitors
JP7083309B2 (ja) 2015-08-04 2022-06-10 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム エルティーディー. ピラゾールピリミジン誘導体及びその使用
AR105967A1 (es) 2015-09-09 2017-11-29 Incyte Corp Sales de un inhibidor de pim quinasa
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
US11072599B2 (en) 2017-02-01 2021-07-27 Biotheryx, Inc. Pyrazole compounds and uses thereof
TW201924683A (zh) 2017-12-08 2019-07-01 美商英塞特公司 用於治療骨髓增生性贅瘤的低劑量組合療法
KR20220081359A (ko) 2019-10-09 2022-06-15 바이엘 악티엔게젤샤프트 살충제로서의 신규 헤테로아릴-트리아졸 화합물
WO2025132870A1 (en) * 2023-12-21 2025-06-26 Glaxosmithkline Intellectual Property (No.4) Limited Chemical compounds and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW245716B (enExample) 1992-12-28 1995-04-21 Takeda Pharm Industry Co
IL113112A (en) * 1994-03-28 2000-06-01 Nissan Chemical Ind Ltd Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them
US5955481A (en) 1994-03-28 1999-09-21 Nissan Chemical Industries, Ltd. Pyridine type thiazolidines
AU712802B2 (en) 1994-10-20 1999-11-18 Nippon Chemiphar Co. Ltd. Quinoline derivatives
BRPI0512261A (pt) 2004-06-17 2008-02-26 Wyeth Corp antagonistas de receptor de hormÈnio liberador de gonadotropina
PL1786812T3 (pl) * 2004-09-03 2012-04-30 Merck Serono Sa Pirydynometylenoazolidynony i ich zastosowanie jako inhibitorów fosfoinozytydów
US20090042773A1 (en) 2004-10-12 2009-02-12 Reinhard Wetzker P13 kinase gamma inhibitors for the treatment of anaemia
EP1916249A1 (en) 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
WO2009064486A2 (en) * 2007-11-15 2009-05-22 Musc Foundation For Research Development Inhibitors of pim protein kinases, compositions, and methods for treating cancer
US8252823B2 (en) 2008-01-28 2012-08-28 New York University Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
MX2011004553A (es) 2008-10-29 2011-07-20 Sirtris Pharmaceuticals Inc Piridina, piridina biciclica y analogos relacionados como moduladores de sirtuina.
US20100331315A1 (en) * 2009-06-18 2010-12-30 Mustapha Haddach Rhodanines and related heterocycles as kinase inhibitors
CN102884062B (zh) 2009-12-23 2016-08-03 嘉世高制药公司 氨基嘧啶激酶抑制剂
AU2012245344B2 (en) 2011-04-22 2017-11-09 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
CN104011046B (zh) 2011-11-04 2017-05-03 嘉世高制药公司 氨基嘧啶激酶抑制剂

Similar Documents

Publication Publication Date Title
JP2015501782A5 (enExample)
RU2014122344A (ru) Аминопиримидиновые ингибиторы киназ
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2016503799A5 (enExample)
JP2019518766A5 (enExample)
ME02452B (me) Sredstva za induciranje apoptoze namijenjena liječenju raka i imunih i autoimunih bolesti
JP2013535491A5 (enExample)
JP2014520898A5 (enExample)
JP2013537203A5 (enExample)
RU2018138828A (ru) Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами
RU2014135401A (ru) Производные пиридона
JP2009263394A5 (enExample)
HRP20160253T1 (hr) Inhibitor benzodiazepinske bromodomene
JP2016513660A5 (enExample)
JP2013502441A5 (enExample)
JP2015531747A5 (enExample)
CN106660974A (zh) 含氨磺酰基的1,2,5‑噁二唑类衍生物、其制备方法及其在医药上的应用
RU2019101220A (ru) Кристаллические формы соединения триазолопиримидина
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
ME02838B (me) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
JP2013525458A5 (enExample)
JP2013509431A5 (enExample)
JP2017502940A5 (enExample)
JP2017508782A5 (enExample)
JP2011502956A5 (enExample)